Effect of activated recombinant factor VII versus tranexamic acid infusion on bleeding during spine surgery, randomized, controlled, double blinded trial
Background: Antifibrinolytic drugs, such as tranexamic acid are medications that facilitate hemostasis and decrease blood loss and the need for blood transfusion during major surgery. Activated recombinant coagulation factor VII is a novel hemostatic agent, studies revealed that it is helpful hemost...
Main Authors: | Hossam A. ELShamaa, Sherif A. ELokda |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2015-04-01
|
Series: | Egyptian Journal of Anaesthesia |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1110184915000021 |
Similar Items
-
Efficacy of Topical Tranexamic Acid in Reducing Blood Loss after Laminectomy and Posterolateral Fusion of the Spine: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial
by: Moslem Shakeri, et al.
Published: (2021-04-01) -
Impact on postoperative bleeding and cost of recombinant activated factor VII in patients undergoing heart transplantation
by: Allison L Hollis, et al.
Published: (2016-01-01) -
Uso de fator VII recombinante ativado para tratamento e profilaxia de grandes sangramentos Use of recombinant activated factor VII for treatment and prophylaxis of major bleeding
by: Flávio Augusto Henriques Vince, et al.
Published: (2009-09-01) -
Successful use of activated recombinant factor VII in life threatening bleeding after thoracic surgery
by: VM Kogler, et al.
Published: (2007-07-01) -
Recombinant activated factor VII in the treatment of intractable non-surgical bleeding following major vascular procedures
by: Končar Igor B., et al.
Published: (2008-01-01)